According to the Zhitong Finance App, Xintai Healthcare (02291) announced that on November 5, 2026, the company spent HK$384,400 to repurchase 27,000 shares at a repurchase price of HK$13.9-14.52 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.